Open AccessCardiogenic Shock due to COVID-19-Related Myocarditis in a 19-Year-Old Autistic Patient
Author(s) -
Greta Pascariello,
Giuliana Cimino,
Emiliano Calvi,
Nicola Bernardi,
Michele Grigolato,
Polyxeni Garyfallidis,
Davide Fabbricatore,
Elisa Pezzola,
C Lombardi,
Marco Metra,
Enrico Vizzardi
Publication year - 2020
Publication title -
journal of medical cases
Language(s) - English
Resource type - Journals
eISSN - 1923-4163
pISSN - 1923-4155
DOI - 10.14740/jmc3517
Subject(s) - medicine , myocarditis , ejection fraction , cardiogenic shock , pneumonia , oliguria , mechanical ventilation , cardiology , covid-19 , shock (circulatory) , anesthesia , disease , myocardial infarction , heart failure , renal function , infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mainly responsible for respiratory involvement but cardiac complications are also reported. Nevertheless, potential life-threatening conditions in young people have not been described. A 19-year-old male autistic patient was admitted with fever and cough. The chest radiography showed viral pneumonia and the nasopharyngeal swab detected SARS-CoV-2. He rapidly developed hypotension, oliguria and increased myocardial injury markers and was treated with adrenaline, antiviral drugs and mechanical ventilation. Echocardiography revealed diffuse myocardial hypo-akinesia and decreased left ventricular ejection fraction (LVEF). After several days of treatment, the patient was weaned off mechanical ventilation, LVEF recovered to 50% and laboratory tests showed a decrease of markers of myocardial injury. Coronavirus disease 2019 (COVID-19) can therefore severely affect myocardium with life-threatening complications and even young people can be involved.